Is IEFA a Good Investment? The Case For and Against (2026)
Last updated August 2026
Short answer
The case for IEFA is simple: low-cost, diversified exposure to MSCI EAFE Investable Market Index (IMI) at a 0.07% expense ratio, anchored by names like ASML, HSBA, ROP. If that is the exposure you want and you do not already own most of it through another fund, IEFA is a strong core holding. The catch is concentration in its top names and overlap with broad-market funds you may already hold. Whether it is a buy comes down to whether you want MSCI EAFE Investable Market Index (IMI) and at what cost. Not a recommendation; Walnut is not an investment adviser.
What are you buying with IEFA?
Tracks the MSCI EAFE Investable Market Index, covering large, mid, and small-cap companies across developed markets in Europe, Australasia, and the Far East (EAFE), while excluding the US and Canada. It holds thousands of stocks led by European and Japanese multinationals such as ASML, Nestle, Novartis, AstraZeneca, and Roche. At a 0.07% expense ratio it is one of the lowest-cost broad international funds and is designed as a core international building block alongside a US equity position. It does not include emerging markets, which require a separate fund such as IEMG.
Largest holdings (approximate as of July 2026; verify on iShares's fund page):
| Rank | Ticker | Company | % of IEFA | |
|---|---|---|---|---|
| 1 | ASML | ASML Holding NV | 3.03% | |
| 2 | HSBA | HSBC Holdings PLC | 1.29% | |
| 3 | ROP | Roche Holding AG Ordinary Shares new | 1.15% | |
| 4 | NOVN | Novartis AG Registered Shares | 1.14% | |
| 5 | AZN | AstraZeneca PLC | 1.12% | |
| 6 | NESN | Nestle SA | 1.05% | |
| 7 | SIE | Siemens AG | 0.95% | |
| 8 | SHEL | Shell PLC | 0.87% | |
| 9 | 8035 | Tokyo Electron Ltd | 0.84% | |
| 10 | 8306 | Mitsubishi UFJ Financial Group Inc | 0.84% |
What's the case for IEFA?
IEFA is the iShares Core MSCI EAFE ETF, a low-cost way to own developed-market stocks outside the US and Canada. It tracks the MSCI EAFE Investable Market Index, holding thousands of large, mid, and small-cap companies across Europe, Australasia, and the Far East, with names like ASML, Nestle, Novartis, and AstraZeneca near the top. At a 0.07% expense ratio it is one of the cheapest broad international funds and a common core building block for international allocation.
In its favour: it gives you MSCI EAFE Investable Market Index (IMI) exposure in one ticker at a 0.07% expense ratio, which is simple to hold and cheap to own.
What should you weigh before buying IEFA?
- Cost vs alternatives: 0.07% is the fee; compare it to funds tracking a similar index.
- Concentration: check how much of IEFA sits in its largest holdings (ASML, HSBA, ROP).
- Overlap: if you already own a broad-market fund, you may already hold much of this.
- Tracking scope: IEFA only gives you MSCI EAFE Investable Market Index (IMI); it will not capture what sits outside that index.
How concentrated is IEFA?
“Diversified” is the word every index fund uses and it hides a wide range. The number that actually matters is how much of the fund sits in its largest positions, because that is the part that drives the return. In IEFA, the three largest positions are about 5.5% of the fund and the 10 largest are about 12.3%, with the single biggest at roughly 3%. Those are approximate weights as of July 2026, and because this is the published top 10 rather than the full book, treat 12.3% as a floor on concentration rather than the whole picture. Verify with iShares.
That is a well spread fund. No small group of names drives it, so the return will track its index closely rather than the fortunes of a handful of companies.
This is also the number that decides whether IEFA adds diversification to your portfolio rather than to a portfolio in the abstract. A fund can be well spread on its own and still concentrate you further, if its largest holdings are names you already own directly or through another fund. That is a question about your account rather than about IEFA, and it is the one worth answering before you buy.
What IEFA does not give you
A fund is defined as much by what it leaves out as by what it holds, and the exclusions are rarely on the marketing page. IEFA tracks MSCI EAFE Investable Market Index (IMI), so anything outside that index is simply absent from your portfolio no matter how much of the fund you own.
In practice that means checking three gaps. Whether the geography you want is covered, since a US index holds no international companies and a developed-markets index holds no emerging ones. Whether the size band you want is covered, because a large-cap index excludes the smaller companies some investors specifically want exposure to. And whether the asset class you want is covered at all, since an equity fund holds no bonds and gives you nothing to rebalance against in a drawdown.
None of these are faults. They are the fund doing exactly what it says. The mistake is assuming that owning a diversified fund means being diversified, when it means being diversified within one index.
When IEFA is the wrong choice
Being specific about this is more useful than another paragraph on why it might be right.
- You already own most of it. If a broad-market fund you hold already contains ASML, HSBA, ROP at meaningful weight, adding IEFA mostly increases your exposure to the same companies while adding a second fee. That is the single most common way people accidentally concentrate.
- You want the exposure for a short horizon. An index fund is a way to own an asset class over years. Over months it is simply the index, with all of the index's volatility and none of the compounding that makes holding it worthwhile.
- You need income you can rely on. Distributions from an equity index fund vary with what the underlying companies pay, so they are not a schedule you can plan around the way a bond ladder is.
- A cheaper fund tracks the same thing. Where two funds follow a similar index, the difference in expense ratio is one of the few advantages available to you without taking extra risk. Compare before assuming 0.07% is competitive.
How do you decide if IEFA is a buy?
The useful question is rarely “will IEFA go up?” It is “does this exposure fit my plan, at a cost I am happy with, without doubling up on what I already own?” Walnut connects your real brokerage so you can see exactly how IEFA would overlap with your current holdings, analyze it by chatting through Claude or ChatGPT, and place any trade yourself. You stay in control.
The bottom line on IEFA
The bottom line: IEFA is a low-cost core building block for MSCI EAFE Investable Market Index (IMI) exposure, not a tactical bet on a single name. If you want MSCI EAFE Investable Market Index (IMI) exposure and the 0.07% fee is competitive for you, it does its job well. If you already own that exposure through another fund, adding it mostly doubles a fee without adding diversification. Decide from your goal and your existing holdings, not from where the market sat last week. Walnut is not an investment adviser.
More on IEFA
- What is IEFA? (holdings, cost, performance, and the themes it covers)
- IEFA dividend: yield and schedule
Investing in IEFA with AI
Connect the broker you already use and ask Walnut's AI how IEFA fits what you actually hold: what it overlaps with, what it leaves you exposed to, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is IEFA a good ETF to buy?
+
Walnut is informational, not investment advice. Whether IEFA fits depends on your goals, time horizon, and what you already hold. It tracks MSCI EAFE Investable Market Index (IMI) at a 0.07% expense ratio, so the questions that matter are whether you want that exposure, whether you already own it through another fund, and whether the cost is competitive for what it does.
What does IEFA actually hold?
+
IEFA tracks MSCI EAFE Investable Market Index (IMI). Its largest positions include ASML, HSBA, ROP, NOVN, AZN and others (approximate, verify on iShares's fund page). The holdings are what you are really buying, not the ticker.
What is IEFA's expense ratio?
+
0.07% as of July 2026. Over decades, the expense ratio is one of the few things you can control, so it is worth comparing against close alternatives that track a similar index.
Does IEFA pay a dividend?
+
IEFA distributes a dividend with an approximate yield of 3.40% (July 2026). See the IEFA dividend page for how distributions work. Verify the current figure with iShares.
What are the risks of buying IEFA?
+
Like any index ETF, weigh concentration (how much sits in the top holdings), overlap with funds you already own, and whether MSCI EAFE Investable Market Index (IMI) matches the exposure you actually want. IEFA only gives you MSCI EAFE Investable Market Index (IMI), not what sits outside it.
How do I decide if IEFA is right for me?
+
Start from your goal, then check four things: what IEFA holds, its cost versus alternatives, how much it overlaps with what you already own, and whether the exposure fits your time horizon and risk tolerance. Walnut can analyze the overlap against your real holdings; you keep your broker and approve any trade.
Walnut is informational, not investment advice. Figures are approximations stamped to July 2026; verify current data with iShares or your broker. Nothing here is a recommendation to buy, sell, or hold any security.